Peripheral blood lymphocytes differentiation patterns in responses / outcomes to immune checkpoint blockade therapies in non-small cell lung cancer: a retrospective studyXiaoyue Du, Bo Shen, Wei Zhu et al.|BMC Cancer|2023Cited by 16
Association between changes in thioredoxin reductase and other peripheral blood biomarkers with response to PD-1 inhibitor-based combination immunotherapy in non-small cell lung cancer: a retrospective studyShaodi Wen, Bo Shen, Xiaoyue Du et al.|Translational Lung Cancer Research|2022Cited by 12
Identification of macrophage-related genes correlated with prognosis and immunotherapy efficacy in non-small cell lung cancerShaodi Wen, Bo Shen, Renrui Zou et al.|Heliyon|2024Cited by 7
The efficacy of neoadjuvant immunotherapy and lymphocyte subset predictors in locally advanced esophageal squamous cell carcinoma: A retrospective studyRuotong Wang, Bo Shen, Miaolin Zhu et al.|Cancer Medicine|2024Cited by 5